ProKidney to Go Public Via Merger with Social Capital Suvretta Holdings Corp. III (DNAC) Jul 12, 2022 08:04AM
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III Jul 12, 2022 08:00AM
ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III (DNAC) Jan 18, 2022 07:01AM
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III Jan 18, 2022 07:00AM